Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|12|2|93-100

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.12, Iss.2, 2017-05, pp. : 93-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IOERT as anticipated tumor bed boost during breast‐conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer—Results of a case series after 5‐year follow‐up

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 5, 2015-03 ,pp. : 1193-1201

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neoadjuvant Therapy for HER2-positive Breast Cancer

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. : 81-92

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapy of HER2-Negative Breast Cancer

By  

Oncology Research and Treatment, Vol. 39, Iss. 3, 2016-02 ,pp. : 118-121

Karger

Access to resources Recommend Favorite

Targeted Therapy in HER2-Positive Breast Cancer

By  

Oncology Research and Treatment, Vol. 39, Iss. 5, 2016-04 ,pp. : 295-302

Karger

Access to resources Recommend Favorite

Change in HER2 status after neoadjuvant chemotherapy and the prognostic impact in patients with primary breast cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 116, Iss. 8, 2017-12 ,pp. : 1021-1028

John Wiley & Sons Inc

Access to resources Recommend Favorite